Year |
Citation |
Score |
2023 |
Tejwani L, Jung Y, Kokubu H, Sowmithra S, Ni L, Lee C, Sanders B, Lee PJ, Xiang Y, Luttik K, Soriano A, Yoon J, Park J, Ro HH, Ju H, ... ... Jafar-Nejad P, et al. Reduction of Nemo-like kinase increases lysosome biogenesis and ameliorates TDP-43-related neurodegeneration. The Journal of Clinical Investigation. PMID 37384409 DOI: 10.1172/JCI138207 |
0.73 |
|
2023 |
Lee D, Chen W, Kaku HN, Zhuo X, Chao ES, Soriano A, Kuncheria A, Flores S, Kim JH, Rivera A, Rigo F, Jafar-Nejad P, Beaudet AL, Caudill MS, Xue M. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome. Elife. 12. PMID 36594817 DOI: 10.7554/eLife.81892 |
0.415 |
|
2022 |
Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, Shneider NA. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nature Medicine. 28: 104-116. PMID 35075293 DOI: 10.1038/s41591-021-01615-z |
0.318 |
|
2021 |
Shao Y, Sztainberg Y, Wang Q, Bajikar SS, Trostle AJ, Wan YW, Jafar-Nejad P, Rigo F, Liu Z, Tang J, Zoghbi HY. Antisense oligonucleotide therapy in a humanized mouse model of duplication syndrome. Science Translational Medicine. 13. PMID 33658357 DOI: 10.1126/scitranslmed.aaz7785 |
0.471 |
|
2020 |
Rodriguez CM, Wright SE, Kearse MG, Haenfler JM, Flores BN, Liu Y, Ifrim MF, Glineburg MR, Krans A, Jafar-Nejad P, Sutton MA, Bassell GJ, Parent JM, Rigo F, Barmada SJ, et al. A native function for RAN translation and CGG repeats in regulating fragile X protein synthesis. Nature Neuroscience. PMID 32066985 DOI: 10.1038/S41593-020-0590-1 |
0.333 |
|
2019 |
Chen CJ, Sgritta M, Mays J, Zhou H, Lucero R, Park J, Wang IC, Park JH, Kaipparettu BA, Stoica L, Jafar-Nejad P, Rigo F, Chin J, Noebels JL, Costa-Mattioli M. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency. Nature Medicine. PMID 31636454 DOI: 10.1038/S41591-019-0608-Y |
0.343 |
|
2018 |
Clayton EL, Milioto C, Muralidharan B, Norona FE, Edgar JR, Soriano A, Jafar-Nejad P, Rigo F, Collinge J, Isaacs AM. Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown. Brain : a Journal of Neurology. 141: 3428-3442. PMID 30496365 DOI: 10.1093/Brain/Awy284 |
0.382 |
|
2018 |
Spiller KJ, Khan T, Dominique MA, Restrepo CR, Cotton-Samuel D, Levitan M, Jafar-Nejad P, Zhang B, Soriano A, Rigo F, Trojanowski JQ, Lee VM. Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice. Neurobiology of Disease. PMID 30458231 DOI: 10.1016/J.Nbd.2018.11.013 |
0.303 |
|
2017 |
Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, Messing J, Kim HJ, Soriano A, Auburger G, Pulst SM, Taylor JP, Rigo F, Gitler AD. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. PMID 28405022 DOI: 10.1038/Nature22038 |
0.411 |
|
2016 |
Rousseaux MW, de Haro M, Lasagna-Reeves CA, De Maio A, Park J, Jafar-Nejad P, Al-Ramahi I, Sharma A, See L, Lu N, Vilanova-Velez L, Klisch TJ, Westbrook TF, Troncoso JC, Botas J, et al. TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. Elife. 5. PMID 27779468 DOI: 10.7554/Elife.19809 |
0.765 |
|
2016 |
Lasagna-Reeves CA, de Haro M, Hao S, Park J, Rousseaux MW, Al-Ramahi I, Jafar-Nejad P, Vilanova-Velez L, See L, De Maio A, Nitschke L, Wu Z, Troncoso JC, Westbrook TF, Tang J, et al. Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model. Neuron. PMID 27720485 DOI: 10.1016/J.Neuron.2016.09.022 |
0.787 |
|
2016 |
Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, Chun S, Sun S, Ling SC, Myers B, Engelhardt J, et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. PMID 27112497 DOI: 10.1016/J.Neuron.2016.04.006 |
0.363 |
|
2016 |
Rousseaux MW, Haro Md, Lasagna-Reeves CA, Maio AD, Park J, Jafar-Nejad P, Al-Ramahi I, Sharma A, See L, Lu N, Vilanova-Velez L, Klisch TJ, Westbrook TF, Troncoso JC, Botas J, et al. Author response: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau Elife. DOI: 10.7554/Elife.19809.028 |
0.758 |
|
2015 |
Lasagna-Reeves CA, Rousseaux MW, Guerrero-Munoz MJ, Vilanova-Velez L, Park J, See L, Jafar-Nejad P, Richman R, Orr HT, Kayed R, Zoghbi HY. Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes. Elife. 4. PMID 26673892 DOI: 10.7554/Elife.10891 |
0.766 |
|
2015 |
Lasagna-Reeves CA, Rousseaux MW, Guerrero-Muñoz MJ, Park J, Jafar-Nejad P, Richman R, Lu N, Sengupta U, Litvinchuk A, Orr HT, Kayed R, Zoghbi HY. A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1. Elife. 4. PMID 25988806 DOI: 10.7554/Elife.07558 |
0.793 |
|
2015 |
Gennarino VA, Singh RK, White JJ, De Maio A, Han K, Kim JY, Jafar-Nejad P, di Ronza A, Kang H, Sayegh LS, Cooper TA, Orr HT, Sillitoe RV, Zoghbi HY. Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell. 160: 1087-98. PMID 25768905 DOI: 10.1016/J.Cell.2015.02.012 |
0.611 |
|
2015 |
Lasagna-Reeves CA, Rousseaux MW, Guerrero-Munoz MJ, Vilanova-Velez L, Park J, See L, Jafar-Nejad P, Richman R, Orr HT, Kayed R, Zoghbi HY. Author response: Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes Elife. DOI: 10.7554/Elife.10891.010 |
0.746 |
|
2015 |
Lasagna-Reeves CA, Rousseaux MW, Guerrero-Muñoz MJ, Park J, Jafar-Nejad P, Richman R, Lu N, Sengupta U, Litvinchuk A, Orr HT, Kayed R, Zoghbi HY. Author response: A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1 Elife. DOI: 10.7554/Elife.07558.025 |
0.748 |
|
2015 |
Lasagna-Reeves CA, Rousseaux MWC, Guerrero-Munoz MJ, Park J, Jafar-Nejad P, Richman R, Lu N, Sengupta U, Litvinchuk A, Orr HT, Kayed R, Zoghbi HY. A native interactor scaffolds and stabilizes toxic Ataxin-1 oligomers in SCA1 Elife. 4: 1-46. DOI: 10.7554/eLife.07558 |
0.773 |
|
2015 |
Rousseaux M, de Haro M, Lasagna-Reeves C, De Maio A, Jafar-Nejad P, Park J, Al-Ramahi I, Kayed R, Botas H, Zoghbi H. TRIM28 regulates the stability and toxicity of alpha-synuclein and tau through a common mechanism Journal of the Neurological Sciences. 357: e285-e286. DOI: 10.1016/J.Jns.2015.08.996 |
0.76 |
|
2015 |
Lasagna-Reeves C, Al Ramahi I, de Haro M, Rousseaux M, Kim J, Jafar-Nejad P, Vilanova-Velez L, Westbrook T, Botas J, Zoghbi H. Targeting tau protein stability in alzheimer disease to identify novel therapeutic entry points Journal of the Neurological Sciences. 357: e131. DOI: 10.1016/J.Jns.2015.08.422 |
0.796 |
|
2013 |
Perroud B, Jafar-Nejad P, Wikoff WR, Gatchel JR, Wang L, Barupal DK, Crespo-Barreto J, Fiehn O, Zoghbi HY, Kaddurah-Daouk R. Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effects. Plos One. 8: e70610. PMID 23936457 DOI: 10.1371/Journal.Pone.0070610 |
0.748 |
|
2013 |
Park J, Al-Ramahi I, Tan Q, Mollema N, Diaz-Garcia JR, Gallego-Flores T, Lu HC, Lagalwar S, Duvick L, Kang H, Lee Y, Jafar-Nejad P, Sayegh LS, Richman R, Liu X, et al. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature. 498: 325-31. PMID 23719381 DOI: 10.1038/Nature12204 |
0.803 |
|
2011 |
Jafar-Nejad P, Ward CS, Richman R, Orr HT, Zoghbi HY. Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3epsilon haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 108: 2142-7. PMID 21245341 DOI: 10.1073/Pnas.1018748108 |
0.663 |
|
2009 |
Elizondo LI, Jafar-Nejad P, Clewing JM, Boerkoel CF. Gene clusters, molecular evolution and disease: a speculation. Current Genomics. 10: 64-75. PMID 19721813 DOI: 10.2174/138920209787581271 |
0.31 |
|
2009 |
Jorgensen ND, Andresen JM, Lagalwar S, Armstrong B, Stevens S, Byam CE, Duvick LA, Lai S, Jafar-Nejad P, Zoghbi HY, Clark HB, Orr HT. Phosphorylation of ATXN1 at Ser776 in the cerebellum. Journal of Neurochemistry. 110: 675-86. PMID 19500214 DOI: 10.1111/J.1471-4159.2009.06164.X |
0.503 |
|
2008 |
Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE, Orr HT, Zoghbi HY. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 452: 713-8. PMID 18337722 DOI: 10.1038/Nature06731 |
0.771 |
|
2008 |
Gatchel JR, Watase K, Thaller C, Carson JP, Jafar-Nejad P, Shaw C, Zu T, Orr HT, Zoghbi HY. The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7. Proceedings of the National Academy of Sciences of the United States of America. 105: 1291-6. PMID 18216249 DOI: 10.1073/Pnas.0711257105 |
0.719 |
|
2007 |
Bowman AB, Lam YC, Jafar-Nejad P, Chen HK, Richman R, Samaco RC, Fryer JD, Kahle JJ, Orr HT, Zoghbi HY. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Nature Genetics. 39: 373-9. PMID 17322884 DOI: 10.1038/Ng1977 |
0.789 |
|
2006 |
Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, Fryer JD, Hyun ED, Duvick LA, Orr HT, Botas J, Zoghbi HY. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell. 127: 1335-47. PMID 17190598 DOI: 10.1016/J.Cell.2006.11.038 |
0.782 |
|
2006 |
Schoch KM, Jafar-nejad P, Rigo F, Miller TM. O4-02-02: TARGETING THE ALZHEIMER'S DISEASE-ASSOCIATED RISK GENE, TREM2
, WITH ANTISENSE OLIGONUCLEOTIDES Alzheimer's & Dementia. 14: P1402-P1403. DOI: 10.1016/J.Jalz.2018.06.2916 |
0.31 |
|
Low-probability matches (unlikely to be authored by this person) |
2021 |
Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M, Jafar-Nejad P, Rigo F, Miller TM. Acute reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34187891 DOI: 10.1073/pnas.2100356118 |
0.271 |
|
2023 |
Luan W, Wright AL, Brown-Wright H, Le S, San Gil R, Madrid San Martin L, Ling K, Jafar-Nejad P, Rigo F, Walker AK. Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD. Molecular Psychiatry. PMID 37012334 DOI: 10.1038/s41380-023-02036-9 |
0.271 |
|
2020 |
Lenk GM, Jafar-Nejad P, Hill SF, Huffman LD, Smolen CE, Wagnon JL, Petit H, Yu W, Ziobro J, Bhatia K, Parent J, Giger RJ, Rigo F, Meisler MH. Scn8a antisense oligonucleotide is protective in mouse models of SCN8A Encephalopathy and Dravet Syndrome. Annals of Neurology. PMID 31943325 DOI: 10.1002/Ana.25676 |
0.259 |
|
2020 |
Jafar-Nejad P, Powers B, Soriano A, Zhao H, Norris DA, Matson J, DeBrosse-Serra B, Watson J, Narayanan P, Chun SJ, Mazur C, Kordasiewicz H, Swayze EE, Rigo F. The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration. Nucleic Acids Research. PMID 33367834 DOI: 10.1093/nar/gkaa1235 |
0.218 |
|
2023 |
Smith DM, Niehoff ML, Ling K, Jafar-Nejad P, Rigo F, Farr SA, Wilkinson MF, Nguyen AD. Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementia. Plos One. 18: e0282822. PMID 36893203 DOI: 10.1371/journal.pone.0282822 |
0.213 |
|
2023 |
López-Erauskin J, Bravo-Hernandez M, Presa M, Baughn MW, Melamed Z, Beccari MS, Agra de Almeida Quadros AR, Arnold-Garcia O, Zuberi A, Ling K, Platoshyn O, Niño-Jara E, Ndayambaje IS, McAlonis-Downes M, Cabrera L, ... ... Jafar-Nejad P, et al. Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation. Nature Neuroscience. PMID 37996528 DOI: 10.1038/s41593-023-01496-0 |
0.203 |
|
2013 |
Salas R, Steele K, Lin A, Loe C, Gauna L, Jafar-Nejad P. Playback Theatre as a tool to enhance communication in medical education. Medical Education Online. 18: 22622. PMID 24369762 DOI: 10.3402/Meo.V18I0.22622 |
0.184 |
|
2023 |
Torazza C, Provenzano F, Gallia E, Cerminara M, Balbi M, Bonifacino T, Tessitore S, Ravera S, Usai C, Musante I, Puliti A, Van Den Bosch L, Jafar-Nejad P, Rigo F, Milanese M, et al. Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes. Cells. 12. PMID 37566031 DOI: 10.3390/cells12151952 |
0.183 |
|
2023 |
Canalis E, Mocarska M, Schilling L, Jafar-Nejad P, Carrer M. Antisense oligonucleotides targeting a NOTCH3 mutation in male mice ameliorate the cortical osteopenia of lateral meningocele syndrome. Bone. 177: 116898. PMID 37704069 DOI: 10.1016/j.bone.2023.116898 |
0.181 |
|
2023 |
Aggarwal G, Banerjee S, Jones SA, Benchaar Y, Bélanger J, Sévigny M, Smith DM, Niehoff ML, Pavlack M, de Vera IMS, Petkau TL, Leavitt BR, Ling K, Jafar-Nejad P, Rigo F, et al. Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation. The Journal of Biological Chemistry. 105475. PMID 37981208 DOI: 10.1016/j.jbc.2023.105475 |
0.178 |
|
2021 |
Gould SA, Gilley J, Ling K, Jafar-Nejad P, Rigo F, Coleman M. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration. Cell Reports. 37: 110108. PMID 34910914 DOI: 10.1016/j.celrep.2021.110108 |
0.171 |
|
2023 |
Rothstein JD, Baskerville V, Rapuri S, Mehlhop E, Jafar-Nejad P, Rigo F, Bennett F, Mizielinska S, Isaacs A, Coyne AN. GC targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons. Acta Neuropathologica. 147: 1. PMID 38019311 DOI: 10.1007/s00401-023-02652-3 |
0.165 |
|
2023 |
Niknejad N, Fox D, Burwinkel JL, Zarrin-Khameh N, Cho S, Soriano A, Cast AE, Lopez MF, Huppert KA, Rigo F, Huppert SS, Jafar-Nejad P, Jafar-Nejad H. Antisense oligonucleotide silencing of a glycosyltransferase, Poglut1, improves the liver phenotypes in mouse models of Alagille syndrome. Hepatology (Baltimore, Md.). PMID 37021797 DOI: 10.1097/HEP.0000000000000380 |
0.154 |
|
2022 |
Hill SF, Ziobro J, Jafar-Nejad P, Rigo F, Meisler MH. Genetic interaction between Scn8a and potassium channel genes Kcna1 and Kcnq2. Epilepsia. PMID 35892317 DOI: 10.1111/epi.17374 |
0.132 |
|
2023 |
Liu P, Chen W, Jiang H, Huang H, Liu L, Fang F, Li L, Feng X, Liu D, Dalal R, Sun Y, Jafar-Nejad P, Ling K, Rigo F, Ye J, et al. Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies. Molecular Therapy. Nucleic Acids. 32: 13-27. PMID 36950280 DOI: 10.1016/j.omtn.2023.02.029 |
0.127 |
|
2021 |
Li M, Jancovski N, Jafar-Nejad P, Burbano LE, Rollo B, Richards K, Drew L, Sedo A, Heighway J, Pachernegg S, Soriano A, Jia L, Blackburn T, Roberts B, Nemiroff A, et al. Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model. The Journal of Clinical Investigation. 131. PMID 34850743 DOI: 10.1172/JCI152079 |
0.122 |
|
2023 |
Hill SF, Jafar-Nejad P, Rigo F, Meisler MH. Reduction of is therapeutic in mouse models of and epilepsy. Frontiers in Neuroscience. 17: 1282201. PMID 37901435 DOI: 10.3389/fnins.2023.1282201 |
0.112 |
|
2023 |
González YR, Kamkar F, Jafar-Nejad P, Wang S, Qu D, Alvarez LS, Hawari D, Sonnenfeld M, Slack RS, Albert PR, Park DS, Joselin A. PFTK1 kinase regulates axogenesis during development via RhoA activation. Bmc Biology. 21: 240. PMID 37907898 DOI: 10.1186/s12915-023-01732-w |
0.111 |
|
2022 |
Spencer ER, Shi W, Komorowski RW, Gilbert JP, Ostrowski LM, Bird LM, Thibert R, Bao C, Molloy F, Calhoun M, Koirala S, Jafar-Nejad P, Rigo F, Kramer MA, Chu CJ. Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome. Brain Communications. 4: fcac106. PMID 35611307 DOI: 10.1093/braincomms/fcac106 |
0.105 |
|
2022 |
Burbano LE, Li M, Jancovski N, Jafar-Nejad P, Richards K, Sedo A, Soriano A, Rollo B, Jia L, Gazina EV, Piltz S, Adikusuma F, Thomas PQ, Kopsidas H, Rigo F, et al. Antisense oligonucleotide therapy for KCNT1 encephalopathy. Jci Insight. PMID 36173683 DOI: 10.1172/jci.insight.146090 |
0.105 |
|
2023 |
Mendonca D, Cappuccio G, Sheppard J, Delacruz M, Bengtsson J, Carvalho CMB, Bajic A, Park H, Kim JJ, Jafar-Nejad P, Coquery C, Pehlivan D, Suter B, Maletic-Savatic M. Generation of five induced pluripotent stem cell lines from patients with MECP2 Duplication Syndrome. Stem Cell Research. 74: 103292. PMID 38154383 DOI: 10.1016/j.scr.2023.103292 |
0.096 |
|
2023 |
Hatch RJ, Berecki G, Jancovski N, Li M, Rollo B, Jafar-Nejad P, Rigo F, Kaila K, Reid CA, Petrou S. Carbogen-induced respiratory acidosis blocks experimental seizures by a direct and specific inhibition of Na1.2 channels in the axon initial segment of pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36732074 DOI: 10.1523/JNEUROSCI.1387-22.2022 |
0.086 |
|
2023 |
Okoh J, Mays J, Bacq A, Oses-Prieto JA, Tyanova S, Chen CJ, Imanbeyev K, Doladilhe M, Zhou H, Jafar-Nejad P, Burlingame A, Noebels J, Baulac S, Costa-Mattioli M. Targeted suppression of mTORC2 reduces seizures across models of epilepsy. Nature Communications. 14: 7364. PMID 37963879 DOI: 10.1038/s41467-023-42922-y |
0.086 |
|
2024 |
Yang S, Niou ZX, Enriquez A, LaMar J, Huang JY, Ling K, Jafar-Nejad P, Gilley J, Coleman MP, Tennessen JM, Rangaraju V, Lu HC. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Molecular Neurodegeneration. 19: 13. PMID 38282024 DOI: 10.1186/s13024-023-00690-9 |
0.082 |
|
2023 |
Yang S, Niou ZX, Enriquez A, LaMar J, Huang JY, Ling K, Jafar-Nejad P, Gilley J, Coleman MP, Tennessen JM, Rangaraju V, Lu HC. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Research Square. PMID 37292715 DOI: 10.21203/rs.3.rs-2859584/v1 |
0.078 |
|
1999 |
Dehpour AR, Jafar-Nejad P, Mani AR, Gharib B, Daryani NE. Chlorpromazine-induced erythrocyte shape change in rats with obstructive cholestasis Pharmacy and Pharmacology Communications. 5: 615-618. DOI: 10.1211/146080899128734235 |
0.061 |
|
1999 |
Dehpour A, Jafar-Nejad P, Mani A, Gharib B, Daryani N. Chlorpromazine-induced Erythrocyte Shape Change in Ratswith Obstructive Cholestasis Pharmacy and Pharmacology Communications. 5: 615-618. DOI: 10.1211/146080899128734235 |
0.033 |
|
2013 |
Salas R, Steele K, Lin A, Loe C, Gauna L, Jafar-Nejad P. Playback Theatre as a tool to enhance communication in medical education. Medical Education Online. 18: 22622. PMID 28166016 DOI: 10.3402/meo.v18i0.22622 |
0.01 |
|
Hide low-probability matches. |